csf tau as a biomarker of therapeutic effect
Published 2 years ago • 64 plays • Length 1:23Download video MP4
Download video MP3
Similar videos
-
2:18
the potential of brain-derived tau as a neurodegeneration biomarker
-
5:21
clinical robustness of csf ptau/aβ42 ratio for alzheimer’s disease diagnosis
-
29:31
complete csf biomarker profile for alzheimer’s disease in the era of automation and standardization
-
15:23
alzheimer's disease csf biomarkers
-
2:51
association of csf and plasma biomarkers with longitudinal tau accumulation
-
2:48
detecting alzheimer's 20 years before onset
-
20:45
tof
-
7:44
you have 3 brains. this is how to use them | robert sapolsky
-
2:24
fluid biomarkers of immune function in alzheimer’s disease
-
1:49
nfl as a biomarker in alzheimer’s
-
1:32
investigating novel plasma-based p-tau biomarkers
-
2:21
strem2 in csf associates with amyloid, tau, and cognition in autosomal-dominant alzheimer's disease
-
1:18
biomarkers in dementia with lewy bodies: αsyn rt-quic
-
2:03
modifiable dementia risk factors associated with higher csf tau and poorer cognition in middle age
-
4:43
preliminary data on the use of sv2a as a biomarker of neurodegeneration in alzheimer’s disease
-
1:14
what do we understand about the secretion of brain p-tau in ad?
-
23:36
introduction of csf biomarkers into routine practice
-
1:41
what is the interest of automated testing for all four main csf biormarkers for alzheimer's disease?
-
4:49
diagnostic utility of csf biomarkers in patients with rapidly progressive dementia
-
36:39
multiplex immunoassay detection of alzheimer's disease biomarker
-
38:50
recent updates on blood and csf biomarkers and dian-tu clinical trial status
-
4:32
plasma tau217 occupancy as accurate as validated csf tests